http://www.unboundmedicine.com/medline/ebm/research/epirubicinUnbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.en-usUnbound Medicine, Inc.http://www.unboundmedicine.com/medline/ebm/record/19915976/full_citation/Fifteen_year_trends_in_metastatic_breast_cancer_survival_in_Greece_Dafni U, Grimani I, Xyrafas A, et al. 
Fifteen-year trends in metastatic breast cancer survival in Greece. [JOURNAL ARTICLE]
Breast Cancer Res Treat 2009 Nov 14.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19913833/full_citation/Should_Patients_With_Primary_Upper_Urinary_Tract_Cancer_Receive_Prophylactic_Intravesical_Chemotherapy_After_NephroureterectomyWu WJ, Ke HL, Yang YH, et al. 
Should Patients With Primary Upper Urinary Tract Cancer Receive Prophylactic Intravesical Chemotherapy After Nephroureterectomy? [JOURNAL ARTICLE]
J Urol 2009 Nov 12.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19906761/full_citation/Randomized_phase_III_trial_comparing_docetaxel_plus_epirubicin_versus_docetaxel_plus_capecitabine_as_first_line_treatment_in_women_with_advanced_breast_cancer_Mavroudis D, Papakotoulas P, Ardavanis A, et al. 
Randomized phase III trial comparing docetaxel plus epirubicin versus docetaxel plus capecitabine as first-line treatment in women with advanced breast cancer. [JOURNAL ARTICLE]
Ann Oncol 2009 Nov 11.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19906561/full_citation/Adjuvant_capecitabine_in_combination_with_docetaxel_and_cyclophosphamide_plus_epirubicin_for_breast_cancer:_an_open_label_randomised_controlled_trial_Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, et al. 
Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial. [JOURNAL ARTICLE]
Lancet Oncol 2009 Nov 9.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19901122/full_citation/Y_Box_Binding_Protein_YB_1_Identifies_High_Risk_Patients_With_Primary_Breast_Cancer_Benefiting_From_Rapidly_Cycled_Tandem_High_Dose_Adjuvant_Chemotherapy_Gluz O, Mengele K, Schmitt M, et al. 
Y-Box-Binding Protein YB-1 Identifies High-Risk Patients With Primary Breast Cancer Benefiting From Rapidly Cycled Tandem High-Dose Adjuvant Chemotherapy. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19901117/full_citation/Cyclophosphamide_Epirubicin_and_Fluorouracil_Versus_Dose_Dense_Epirubicin_and_Cyclophosphamide_Followed_by_Paclitaxel_Versus_Doxorubicin_and_Cyclophosphamide_Followed_by_Paclitaxel_in_Node_Positive_or_High_Risk_Node_Negative_Breast_Cancer_Burnell M, Levine MN, Chapman JA, et al. 
Cyclophosphamide, Epirubicin, and Fluorouracil Versus Dose-Dense Epirubicin and Cyclophosphamide Followed by Paclitaxel Versus Doxorubicin and Cyclophosphamide Followed by Paclitaxel in Node-Positive or High-Risk Node-Negative Breast Cancer. [JOURNAL ARTICLE]
J Clin Oncol 2009 Nov 9.
Abstract | Full Citation | Publisher Full Text | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19897085/full_citation/The_role_of_the_somatotrophic_axis_in_neuroprotection_and_neuroregeneration_of_the_addictive_brain_Nyberg F 
The role of the somatotrophic axis in neuroprotection and neuroregeneration of the addictive brain. [Journal Article, Research Support, Non-U.S. Gov't]
Int Rev Neurobiol 2009.:399-427.
Abstract | Full Citationhttp://www.unboundmedicine.com/medline/ebm/record/19888794/full_citation/Information_technology_facilitates_cost_effectiveness_analysis_in_developing_countries:_an_observational_study_of_breast_cancer_chemotherapy_in_taiwan_Shih YC, Pan IW, Tsai YW 
Information technology facilitates cost-effectiveness analysis in developing countries: an observational study of breast cancer chemotherapy in taiwan. [Journal Article]
Pharmacoeconomics 2009; 27(11):947-61.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19885591/full_citation/hSSTR2_expression_and_octreotide_treatment_reverses_multidrug_resistance_of_BxPC_3_human_pancreatic_cancer_cells_Sui C, Ma Q, Nan K, et al. 
hSSTR2 expression and octreotide treatment reverses multidrug resistance of BxPC-3 human pancreatic cancer cells. [JOURNAL ARTICLE]
Oncol Rep 2009 Dec; 22(6):1391-1396.
Abstract | Full Citation | Find Related Articles http://www.unboundmedicine.com/medline/ebm/record/19884644/full_citation/Evidence_for_direct_involvement_of_epirubicin_in_the_formation_of_chromosomal_translocations_in_t_15;17__therapy_related_acute_promyelocytic_leukemia_Mays AN, Osheroff N, Xiao Y, et al. 
Evidence for direct involvement of epirubicin in the formation of chromosomal translocations in t(15;17) therapy-related acute promyelocytic leukemia. [JOURNAL ARTICLE]
Blood 2009 Nov 2.
Abstract | Full Citation | Publisher Full Text | Find Related Articles